Combination-therapy cyclosporin-A--etretinate for psoriasis. 1990

M J Korstanje, and W J van de Staak
Department of Dermatology, Academic Hospital Maastricht, The Netherlands.

Five patients with therapy-resistant plaque-type psoriasis were treated with cyclosporin. In cases where cyclosporin was not effective or in cases of relapse, etretinate was added. No additive therapeutic effect of etretinate was observed.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005050 Etretinate An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic. B10-9359,Ethyl Etrinoate,Ro 10-9359,Ro-10-9359,Tigason,Tigazon,B10 9359,B109359,Etrinoate, Ethyl,Ro 10 9359,Ro 109359,Ro109359
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M J Korstanje, and W J van de Staak
January 1986, Journal of the American Academy of Dermatology,
M J Korstanje, and W J van de Staak
January 1990, Acta dermato-venereologica,
M J Korstanje, and W J van de Staak
May 1997, Journal of the American Academy of Dermatology,
M J Korstanje, and W J van de Staak
November 1998, The Journal of dermatology,
M J Korstanje, and W J van de Staak
April 1988, Harefuah,
M J Korstanje, and W J van de Staak
February 1993, Journal of the American Academy of Dermatology,
M J Korstanje, and W J van de Staak
October 1983, Archives of dermatology,
M J Korstanje, and W J van de Staak
January 1987, The Medical letter on drugs and therapeutics,
M J Korstanje, and W J van de Staak
November 1998, Journal of the European Academy of Dermatology and Venereology : JEADV,
M J Korstanje, and W J van de Staak
January 1983, Dermatologica,
Copied contents to your clipboard!